METHANEX CORP MEOH

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived Nasdaq

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.59B$3.72B$3.72B$4.31B$4.41B$2.65B$3.28B$4.48B$3.06B$2.00B
Operating income $431.1M$362.0M$263.6M$610.6M$712.0M-$52.5M$189.4M$829.6M$476.5M$28.4M
Net income $144.8M$250.2M$284.1M$462.3M$555.9M-$125.3M$116.4M$658.0M$375.1M-$28.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets $7.28B$6.60B$6.43B$6.63B$6.09B$5.70B$5.20B$4.61B$4.61B$4.56B
Total equity $2.73B$2.38B$2.17B$2.43B$1.95B$1.44B$1.63B$1.81B$1.75B$1.81B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-26-015362.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -2B 0 2B 4B 6B Revenue, FY2016: 2B Net income, FY2016: -28.2M Revenue, FY2017: 3.1B Net income, FY2017: 375.1M Revenue, FY2018: 4.5B Net income, FY2018: 658M Revenue, FY2019: 3.3B Net income, FY2019: 116.4M Revenue, FY2020: 2.6B Net income, FY2020: -125.3M Revenue, FY2021: 4.4B Net income, FY2021: 555.9M Revenue, FY2022: 4.3B Net income, FY2022: 462.3M Revenue, FY2023: 3.7B Net income, FY2023: 284.1M Revenue, FY2024: 3.7B Net income, FY2024: 250.2M Revenue, FY2025: 3.6B Net income, FY2025: 144.8M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.00B $3.06B $4.48B $3.28B $2.65B $4.41B $4.31B $3.72B $3.72B $3.59B
Gross profit — — — — — — — — — —
Net income -$28.2M $375.1M $658.0M $116.4M -$125.3M $555.9M $462.3M $284.1M $250.2M $144.8M

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%